Beijing Aosaikang Pharmaceutical Co., Ltd. is engages in the research, development, production and sale of drugs. Its products include decitabine, fludarabine phosphate, nedaplatin, oxaliplatin, pemetrexed disodium, palonosetron hydrochloride, topotecan hydrochloride, zoledronic acid, temozolomide, tigencycline, lansoprazole, omeprazole, and parecoxib sodium. The company was founded on December 24, 1996 and is headquartered in Nanjing, China.